213 related articles for article (PubMed ID: 16078405)
1. Sticking to the knitting: CIHR, innovation and Canadian biotech.
Edelson J
Healthc Q; 2005; 8(3):65-8. PubMed ID: 16078405
[TBL] [Abstract][Full Text] [Related]
2. Medical entrepreneurism: the current opportunity in America.
Lexa FJ
J Am Coll Radiol; 2004 Oct; 1(10):762-8. PubMed ID: 17411697
[TBL] [Abstract][Full Text] [Related]
3. Venture Capital Investment in the Life Sciences in Switzerland.
Hosang M
Chimia (Aarau); 2014 Dec; 68(12):847-9. PubMed ID: 26508600
[TBL] [Abstract][Full Text] [Related]
4. How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation.
Reed SD; Califf RM; Schulman KA
Health Aff (Millwood); 2006; 25(5):1309-17. PubMed ID: 16966727
[TBL] [Abstract][Full Text] [Related]
5. Health care innovation: progress report and focus on biotechnology.
Read JL; Lee KB
Health Aff (Millwood); 1994; 13(3):215-25. PubMed ID: 7927152
[TBL] [Abstract][Full Text] [Related]
6. Market entry and exit by biotech and device companies funded by venture capital.
Burns LR; Housman MG; Robinson CA
Health Aff (Millwood); 2009; 28(1):w76-86. PubMed ID: 19049998
[TBL] [Abstract][Full Text] [Related]
7. Fostering a new dialogue to improve access to finance for European biopharma SMEs.
Chantelot E; Suojanen C
N Biotechnol; 2010 Dec; 27(6):719-23. PubMed ID: 20678597
[TBL] [Abstract][Full Text] [Related]
8. A venture capital view of challenges, opportunities, and innovation in biomedical research.
Ratcliffe LT
Clin Pharmacol Ther; 2011 Feb; 89(2):174-6. PubMed ID: 21252935
[TBL] [Abstract][Full Text] [Related]
9. Fueling innovation in medical devices (and beyond): venture capital in health care.
Ackerly DC; Valverde AM; Diener LW; Dossary KL; Schulman KA
Health Aff (Millwood); 2009; 28(1):w68-75. PubMed ID: 19049999
[TBL] [Abstract][Full Text] [Related]
10. The decline of venture capital investment in early-stage life sciences poses a challenge to continued innovation.
Fleming JJ
Health Aff (Millwood); 2015 Feb; 34(2):271-6. PubMed ID: 25646107
[TBL] [Abstract][Full Text] [Related]
11. The Canada Pension Plan's experience with investing its portfolio in equities.
Sarney M; Preneta AM
Soc Secur Bull; 2001-2002; 64(2):46-56. PubMed ID: 12428509
[TBL] [Abstract][Full Text] [Related]
12. The winding journey of biotech capital raising: deciphering the jargon.
Frame N; Casasanta M; Ben-Joseph O
Trends Biotechnol; 2023 Oct; 41(10):1213-1215. PubMed ID: 37451947
[TBL] [Abstract][Full Text] [Related]
13. Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic.
Eren Vural I; Herder M; Doll A; Graham JE
Int J Health Policy Manag; 2023; 12():6936. PubMed ID: 37579382
[TBL] [Abstract][Full Text] [Related]
14. Preserving our intellectual capital: the Canadian Institutes of Health Research funding crisis.
Phillipson EA
CMAJ; 2003 Sep; 169(6):568-9. PubMed ID: 12975224
[No Abstract] [Full Text] [Related]
15. Life support for life science innovation?
Nat Biotechnol; 2007 Feb; 25(2):144. PubMed ID: 17287731
[TBL] [Abstract][Full Text] [Related]
16. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
[TBL] [Abstract][Full Text] [Related]
17. Japanese firms broaden investment focus to early biotech.
Louët S; Sipp D
Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
[No Abstract] [Full Text] [Related]
18. Role of Business Models in Funding the Biotech Industry: Global Trends and Challenges for Cuban Biotechnology.
Blanco-García E
MEDICC Rev; 2020 Jan; 22(1):11-16. PubMed ID: 32327617
[TBL] [Abstract][Full Text] [Related]
19. Venture funding for science-based African health innovation.
Masum H; Chakma J; Simiyu K; Ronoh W; Daar AS; Singer PA
BMC Int Health Hum Rights; 2010 Dec; 10 Suppl 1(Suppl 1):S12. PubMed ID: 21144072
[TBL] [Abstract][Full Text] [Related]
20. Biotech's perfect storm.
Karberg S
Cell; 2009 Aug; 138(3):413-5. PubMed ID: 19665960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
